1-6 of 6
James J. Hsieh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, Marc Matrana, Ivor Percent, James J. Hsieh, Arif Hussain, Ulka Vaishampayan, Sandy Liu, Steven McCune, Vijay Patel, Montaser Shaheen, Johanna Bendell, Alice C. Fan, Benjamin A. Gartrell, Oscar B. Goodman, Jr, Petros G. Nikolinakos, Arash Rezazadeh Kalebasty, Yousef Zakharia, Zhentao Zhang, Hema Parmar, Lalith Akella, Keith Orford, Nizar M. Tannir
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3248–3255.
https://doi.org/10.1158/1078-0432.CCR-22-0061
Published: 02 August 2022
View article titled, Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Open the PDF for Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial in another window
Includes: Supplementary data
Journal Articles

Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer

Russell K. Pachynski, Eric H. Kim, Natalia Miheecheva, Nikita Kotlov, Akshaya Ramachandran, Ekaterina Postovalova, Ilia Galkin, Viktor Svekolkin, Yang Lyu, Qiong Zou, Dengfeng Cao, Joseph Gaut, Joseph E. Ippolito, Alexander Bagaev, Maria Bruttan, Olga Gancharova, Krystle Nomie, Maria Tsiper, Gerald L. Andriole, Ravshan Ataullakhanov, James J. Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (12): 3478–3490.
https://doi.org/10.1158/1078-0432.CCR-20-4217
Published: 15 June 2021
View article titled, Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer
Open the PDF for Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

PTEN Expression, Not Mutation Status in TSC1, TSC2, or mTOR, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 Trial

Martin H. Voss, David Chen, Albert Reising, Mahtab Marker, Jiayuan Shi, Jianning Xu, Irina Ostrovnaya, Venkatraman E. Seshan, Almedina Redzematovic, Ying-Bei Chen, Parul Patel, Xia Han, James J. Hsieh, A. Ari Hakimi, Robert J. Motzer
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (2): 506–514.
https://doi.org/10.1158/1078-0432.CCR-18-1833
Published: 15 January 2019
View article titled, PTEN Expression, Not Mutation Status in <em>TSC1, TSC2</em>, or <em>mTOR</em>, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 Trial
Open the PDF for PTEN Expression, Not Mutation Status in <em>TSC1, TSC2</em>, or <em>mTOR</em>, Correlates with the Outcome on Everolimus in Patients with Renal Cell Carcinoma Treated on the Randomized RECORD-3 Trial in another window
Includes: Supplementary data
Journal Articles

Therapeutic Guide for mTOuRing through the Braided Kidney Cancer Genomic River

Martin H. Voss, James J. Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (10): 2320–2322.
https://doi.org/10.1158/1078-0432.CCR-16-0035
Published: 12 May 2016
View article titled, Therapeutic Guide for mTOuRing through the Braided Kidney Cancer Genomic River
Open the PDF for Therapeutic Guide for mTOuRing through the Braided Kidney Cancer Genomic River in another window
Journal Articles

Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy

Martin H. Voss, A. Ari Hakimi, Can G. Pham, A. Rose Brannon, Ying-Bei Chen, Luis F. Cunha, Oguz Akin, Han Liu, Shugaku Takeda, Sasinya N. Scott, Nicholas D. Socci, Agnes Viale, Nikolaus Schultz, Chris Sander, Victor E. Reuter, Paul Russo, Emily H. Cheng, Robert J. Motzer, Michael F. Berger, James J. Hsieh
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (7): 1955–1964.
https://doi.org/10.1158/1078-0432.CCR-13-2345
Published: 31 March 2014
View article titled, Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
Open the PDF for Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network

A. Ari Hakimi, Irina Ostrovnaya, Boris Reva, Nikolaus Schultz, Ying-Bei Chen, Mithat Gonen, Han Liu, Shugaku Takeda, Martin H. Voss, Satish K. Tickoo, Victor E. Reuter, Paul Russo, Emily H. Cheng, Chris Sander, Robert J. Motzer, James J. Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (12): 3259–3267.
https://doi.org/10.1158/1078-0432.CCR-12-3886
Published: 13 June 2013
View article titled, Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators <em>BAP1</em> and <em>SETD2</em>: A Report by MSKCC and the KIRC TCGA Research Network
Open the PDF for Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators <em>BAP1</em> and <em>SETD2</em>: A Report by MSKCC and the KIRC TCGA Research Network in another window
Includes: Supplementary data